Korístková B, Grundmann M
Fakultní nemocnice v Ostrave a Zdravotne sociálni fakulta Ostravské univerzity v Ostrave, Ustav klinické farmakologie.
Ceska Slov Farm. 2006 Jan;55(1):18-23.
Drug utilization expresses the exposition of a drug in the relationship with determined population, certain time period, and specific socioeconomic background. The aim of this study was to compare the antiepileptic drug utilization (N03A) in the Czech Republic (CR) and in Ostrava University Hospital (FNsP). The sources of the data were I) wholesale data (SUKL, CR), II) prescriptions (UZIS, CR), III) request forms (FNsP), IV) request forms for therapeutic drug monitoring (FNsP). The utilization was expressed in DDD/TID (I, II), or in DDD/100 BD in neurological departments (III) on 5th or 4th level, resp. ATC/DDD index 2001, for levetiracetam 2004. Carbamazepine had the highest utilization that was increasing in the CR, while remaining high and constant in FNsP. The utilization of valproic acid is increasing. The number of patients shows greater prescription than utilization in DDD. The utilization of phenytoin was high in the CR, but diminished in FNsP. The number of patients was lower than expected. The utilization of barbiturates was considerable in the CR, but below the average in FNsP. The utilization of clonazepam and N03AX was increasing. The most important substance there was lamotrigin. The outcomes are in agreement with current recommendations. The utilization in FNsP and CR follows the same trend with a faster shift to newer drugs in FNsP.
药物利用情况体现了药物在特定人群、特定时间段以及特定社会经济背景下的使用情况。本研究旨在比较捷克共和国(CR)和俄斯特拉发大学医院(FNsP)的抗癫痫药物使用情况(N03A)。数据来源为:I)批发数据(捷克药品批发协会,CR),II)处方(捷克国家健康信息系统,CR),III)申请表(FNsP),IV)治疗药物监测申请表(FNsP)。药物使用情况以限定日剂量/日(I、II)或神经科第5或4级的限定日剂量/100床日(III)表示,分别采用2001年的解剖学治疗学及化学分类系统/限定日剂量索引,左乙拉西坦采用2004年的索引。卡马西平的使用量最高,在CR呈上升趋势,而在FNsP保持高位且稳定。丙戊酸的使用量在增加。患者数量显示出的处方量高于限定日剂量的使用量。苯妥英钠在CR的使用量较高,但在FNsP有所减少。患者数量低于预期。巴比妥类药物在CR的使用量可观,但在FNsP低于平均水平。氯硝西泮和N03AX的使用量在增加。其中最重要的药物是拉莫三嗪。研究结果与当前建议一致。FNsP和CR的药物使用情况遵循相同趋势,FNsP向新药的转变更快。